Caffeine Tablet

DRUG5 trials

Sponsors

Mayo Clinic, Wills Eye, Children's Mercy Hospital Kansas City, Eli Lilly and Company, Helsinki University Central Hospital

Conditions

Adolescent Idiopathic ScoliosisDrug InteractionGlaucoma, Primary Open AngleHealthyMolecular Imaging

Phase 1

Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue

CompletedNCT01944215

Mayo ClinicMolecular Imaging

Start: 2013-09-30End: 2015-04-30Updated: 2017-04-18

A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9, CYP2C19 Substrates in Healthy Participants

CompletedNCT06215430

Eli Lilly and CompanyHealthy

Start: 2021-01-11End: 2021-04-15Updated: 2025-03-10

Phase 4

Oral Caffeine Use for Pain Management in AIS Patients After Spinal Fusion

CompletedNCT04950660

Children's Mercy Hospital Kansas CityAdolescent Idiopathic Scoliosis

Start: 2019-12-11End: 2024-08-01Updated: 2025-02-21

Unknown Phase

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

RecruitingNCT03675412

Wills EyeGlaucoma, Primary Open Angle

Start: 2018-12-30End: 2026-12-31Target: 80Updated: 2025-11-14

KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism

CompletedNCT06566794

Helsinki University Central HospitalDrug Interaction

Start: 2024-08-22End: 2025-01-10Updated: 2026-03-06